Therasense Inc
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision … Read more
Therasense Inc (THER) - Total Assets
Latest total assets as of December 2023: $2.85 Million USD
Based on the latest financial reports, Therasense Inc (THER) holds total assets worth $2.85 Million USD as of December 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Therasense Inc - Total Assets Trend (2007–2023)
This chart illustrates how Therasense Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Therasense Inc - Asset Composition Analysis
Current Asset Composition (September 2023)
Therasense Inc's total assets of $2.85 Million consist of 44.3% current assets and 55.7% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 35.0% |
| Accounts Receivable | $23.91K | 0.8% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2023)
This chart illustrates how Therasense Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Therasense Inc's current assets represent 44.3% of total assets in 2023, a decrease from 100.0% in 2007.
- Cash Position: Cash and equivalents constituted 35.0% of total assets in 2023, down from 100.0% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 0.8% of total assets.
Therasense Inc Competitors by Total Assets
Key competitors of Therasense Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Therasense Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Therasense Inc generates 0.21x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Therasense Inc is currently not profitable relative to its asset base.
Therasense Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.03 | 0.01 | 0.09 |
| Quick Ratio | 0.03 | 0.01 | 0.07 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-38.57 Million | $ -52.98 Million | $ -3.73 Million |
Therasense Inc - Advanced Valuation Insights
This section examines the relationship between Therasense Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 9.7% |
| Total Assets | $2.85 Million |
| Market Capitalization | $106.97K USD |
Valuation Analysis
Below Book Valuation: The market values Therasense Inc's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Therasense Inc's assets grew by 9.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Therasense Inc (2007–2023)
The table below shows the annual total assets of Therasense Inc from 2007 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-09-30 | $2.85 Million | +9.65% |
| 2022-09-30 | $2.60 Million | +58.61% |
| 2021-09-30 | $1.64 Million | -48.73% |
| 2020-09-30 | $3.20 Million | +3292.76% |
| 2019-09-30 | $94.20K | +246.86% |
| 2018-09-30 | $27.16K | -52.61% |
| 2017-09-30 | $57.31K | -92.11% |
| 2016-09-30 | $726.64K | +621.16% |
| 2014-09-30 | $100.76K | -87.18% |
| 2013-09-30 | $785.67K | -30.37% |
| 2012-09-30 | $1.13 Million | -27.13% |
| 2011-09-30 | $1.55 Million | +22805.64% |
| 2010-09-30 | $6.76K | +176.14% |
| 2009-09-30 | $2.45K | +871.43% |
| 2008-09-30 | $252.00 | -98.97% |
| 2007-09-30 | $24.37K | -- |